Dimensional Fund Advisors LP Purchases 58,434 Shares of Intuitive Surgical, Inc. $ISRG

Dimensional Fund Advisors LP boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 623,301 shares of the medical equipment provider’s stock after acquiring an additional 58,434 shares during the period. Dimensional Fund Advisors LP owned 0.17% of Intuitive Surgical worth $278,737,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Tobam raised its holdings in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $27,000. Greykasell Wealth Strategies Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $27,000. Caitlin John LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $30,000. Finally, Guerra Advisors Inc acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $37,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on ISRG shares. BTIG Research reissued a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a research note on Friday, January 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Evercore dropped their target price on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research report on Friday, January 23rd. Finally, Citigroup reissued a “neutral” rating and issued a $590.00 price target (down from $635.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $615.86.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $490.16 on Friday. The company’s 50 day simple moving average is $521.64 and its 200 day simple moving average is $512.05. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The firm has a market capitalization of $174.07 billion, a price-to-earnings ratio of 62.12, a PEG ratio of 3.83 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.21 earnings per share. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, SVP Mark Brosius sold 4,500 shares of the firm’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the sale, the senior vice president owned 907 shares of the company’s stock, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Gary S. Guthart sold 24,500 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the transaction, the director owned 3,694 shares in the company, valued at approximately $1,958,189.40. This represents a 86.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 37,261 shares of company stock worth $19,690,721 over the last quarter. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.